Cogent Biosciences, Inc. 8-K Filing Report - February 25, 2025

Based on the provided section of a financial report, here are the key pieces of information extracted:

Company Information:

Name: Cogent Biosciences, Inc.
Incorporation State: Delaware (DE)
CIK Number: 0001622229
SEC File Number: 001-38443
EIN: 46-5308248
Address: 275 Wyman Street, 3rd Floor, Waltham, MA 02451
Phone Number: (617) 945-5576

Filing Details:

Filing Type: 8-K
Filing Date: February 25, 2025

Stock Information:

Type of Stock: Common stock
Par Value: $0.001
Trading Symbol: COGT
Exchange: NASDAQ

Period of Report:

Report Date: February 25, 2025

This information indicates that Cogent Biosciences, Inc. filed an 8-K form with the SEC on February 25, 2025. The filing reflects corporate actions or significant events that may be crucial for investors and stakeholders in understanding the company's current status and future outlook.